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Objective: The objective of this study was to investigate the association between self-reported 
sleep duration and the incidence of features of the metabolic syndrome in adults. Methods: A 
longitudinal analysis from the Quebec Family Study (Canada) was conducted on 293 
participants, aged 18 to 65 years, followed for a mean of 6 years (until 2001). Participants were 
categorized as short (≤ 6 h), adequate (7–8 h) or long (≥ 9 h) sleepers. The metabolic syndrome 
was defined according to the American Heart Association/National Heart, Lung, and Blood 
Institute's criteria. The hypertriglyceridemic waist phenotype was defined as high waist 
circumference (≥ 90 cm in men and ≥ 85 cm in women) combined with high fasting triglyceride 
level (≥ 2.0 mmol/L in men and ≥ 1.5 mmol/L in women). Results: The incidence rates of 
metabolic syndrome and hypertriglyceridemic waist phenotype were 9.9% and 7.5%, 
respectively. Short sleepers were significantly more at risk of developing the metabolic 
syndrome (relative risk (RR): 1.74; 95% confidence interval (CI): 1.05–2.72) and the 
hypertriglyceridemic waist phenotype (RR: 1.82; 95% CI: 1.16–2.79), compared to those 
sleeping 7 to 8 h per night after adjusting for covariates. However, long sleep duration was not 
associated with an increased risk of developing the metabolic syndrome or the 
hypertriglyceridemic waist phenotype (either unadjusted or adjusted models). Conclusion: Short 
sleep duration is associated with an increased risk of developing features of the metabolic 
syndrome in adults. 
 






Chronic sleep deprivation is increasingly common in modern society (Akerstedt and Nilsson, 
2003, Matricciani et al., 2012). Insufficient sleep adversely impacts health possibly through 
deleterious metabolic and endocrine perturbations that affect a variety of systems in the body 
(Leproult and Van Cauter, 2010, Spiegel et al., 2009). Previous epidemiologic studies have 
shown that both short and long sleep durations are associated with poor health outcomes 
including obesity (Chaput et al., 2008, Patel and Hu, 2008), type 2 diabetes (Cappuccio et al., 
2010a, Chaput et al., 2009a), coronary heart disease (Cappuccio et al., 2011, King et al., 2008), 
hypertension (Gangwisch et al., 2006, Knutson et al., 2009), and premature death (Cappuccio et 
al., 2010b, Gallicchio and Kalesan, 2009). Although the association between sleep duration and 
health indicators has been reported to be U-shaped in many studies, the adverse effects of 
inadequate sleep appear far more important in today's environment (Knutson and Turek, 2006). 
In particular, the association between long sleep duration and the metabolic syndrome appears to 
be explained by residual confounding factors and comorbidity (Ju and Choi, 2013). 
 
The metabolic syndrome represents a cluster of cardiometabolic risk factors and is an important 
public health concern (Després and Lemieux, 2006). A simple screening tool to help clinicians 
identify individuals with clustering metabolic abnormalities and those at increased coronary 
artery disease risk is the hypertriglyceridemic waist phenotype. The combined measurement of 
waist circumference (≥ 90 cm in men and ≥ 85 cm in women) and fasting triglyceride levels 
(≥ 2.0 mmol/L in men and ≥ 1.5 mmol/L in women) is an inexpensive and clinically useful test 
for the early screening of individuals at risk for atherogenic and diabetogenic features of the 
metabolic syndrome (Blackburn et al., 2009, Blackburn et al., 2012, Lemieux et al., 
2000, Lemieux et al., 2007). 
 
Although sleep is important for the normal functioning of metabolic and hormonal processes, 
only one study to date has examined the association between sleep duration and the incidence of 
metabolic syndrome. In a Korean cohort of adults aged 40 to 70 years, Choi et al. (2011) showed 
that short sleep duration was a significant risk factor for the development of metabolic syndrome 
in women over a follow-up period of 2–4 years. However, they did not control for several 
important variables that could confound the association between short sleep duration and the 
development of metabolic syndrome (e.g. energy intake, cardiorespiratory fitness, 
socioeconomic status) and only relied on Koreans for whom different waist circumference cut-
offs are recommended. Therefore, more studies are needed to prospectively examine the 
association between sleep duration and the metabolic syndrome to better understand the potential 
contribution of sleep as a predictor of cardiometabolic risk. 
 
The main objective of this observational, longitudinal study was to investigate the relationship 
between sleep duration and the development of metabolic syndrome in adults from the greater 
Quebec City area (Canada). We hypothesized that short sleepers (≤ 6 h per night) would be more 
at risk of developing the metabolic syndrome and the hypertriglyceridemic waist phenotype than 






The Quebec Family Study was initiated at Laval University in 1978. The primary objective of 
this study was to investigate the role of genetics in the etiology of obesity and related 
cardiovascular risk factors. In phase 1 of the study (1978 to 1981), a total of 1650 individuals 
from 375 families were recruited and assessed. Recruitment was conducted irrespective of body 
weight during phase 1, resulting in a cohort with a wide range of body mass index, ranging from 
13.8 to 64.9 kg/m2. In phases 2 (1989–1994) and 3 (1995–2001), 100 families from phase 1 were 
retested, and an additional 123 families with at least 1 parent and 1 offspring with a body mass 
index of 32 kg/m2 or higher were added to the cohort. Families were recruited through the media 
and were all French Canadians from the greater Quebec City area. Details of recruitment 
procedures have been published elsewhere (Bouchard, 1996). This cohort thus represents a 
mixture of random sampling and ascertainment through obese individuals. The present analyses 
are based on participants tested in phases 2 and 3 because some measurements were not available 
in phase 1. Adults between 18 and 65 years of age were selected for longitudinal analyses 
(n = 293). A total of 23 participants were excluded because they were outside this age range. The 
mean duration of follow-up between phases 2 and 3 was 6.0 ± 0.9 years. All subjects provided 
written informed consent to participate in the study. The project was approved by the Medical 
Ethics Committee of Laval University. 
 
Sleep duration assessment 
 
The number of hours of sleep was assessed at baseline and year 6 with a question that was 
inserted into a self-administered questionnaire on physical activity participation. The question 
was formulated as follows: “On average, how many hours do you sleep a day?” We classified the 
participants into 3 sleep duration groups: short sleepers (≤ 6 h of sleep), adequate sleepers (7–8 h 
of sleep) and long sleepers (≥ 9 h of sleep), in agreement with our recent papers (Chaput et al., 
2007, Chaput et al., 2009b). We elected to classify the participants into 3 sleep duration groups 
because of the U-shaped relationship that has been previously noted between sleep duration and 
several health outcomes. Epidemiological evidence indicates that a daily sleep duration of 7–8 h 
is optimal, and is associated with an overall good health status in adults (Bixler, 2009). 
 
Metabolic syndrome assessment 
 
Components of the metabolic syndrome were assessed in the morning following a 12-h overnight 
fast at baseline and year 6. Systolic (SBP) and diastolic (DBP) blood pressure measurements 
were obtained by trained staff, using a mercury sphygmomanometer and cuff size appropriate to 
the participant's arm circumference. Blood pressure was calculated as the mean of two 
consecutive readings obtained on the right arm, in a seated position, and following 10 min of 
rest. Body weight, height and waist circumference (WC) (midpoint of the lowest rib and iliac 
crest) were measured according to standardized procedures (The Airlie, VA Consensus 
Conference, 1988), and body mass index (BMI) was calculated as body weight divided by height 
squared (kg/m2). Study staff also collected a venous blood sample to measure fasting serum 
lipids, glucose, and insulin concentrations, as previously described (Chaput et al., 2007). The 
metabolic syndrome was defined according to the American Heart Association/National Heart, 
Lung, and Blood Institute's criteria (Grundy et al., 2005) as the presence of three or more of the 
following risk factors: (i) waist circumference greater than 102 cm in men or greater than 88 cm 
in women; (ii) fasting serum glucose of 5.6 mmol/L or greater, or the use of oral hypoglycemic 
medication; (iii) systolic and diastolic blood pressures of at least 130 mm Hg and 85 mm Hg, 
respectively, or the use of antihypertensive medication; (iv) serum triglyceride levels of 
1.7 mmol/L or higher, or the use of medication for hypertriglyceridemia; and (v) high-density 
lipoprotein (HDL) cholesterol levels of less than 1.03 mmol/L in men or 1.29 mmol/L in women, 
or the use of medication for low HDL cholesterol. 
 
For exploratory purposes, we also calculated a continuous metabolic syndrome risk score for 
each participant by adding up Z scores for each variable as follows: 
 
Continuous metabolic syndrome risk score
= −𝑧𝑧Insulin + 𝑧𝑧Glucose + 𝑧𝑧Triglycerides + (𝑧𝑧BMI + 𝑧𝑧WC) 2⁄
+ (𝑧𝑧SBP + 𝑧𝑧DBP) 2.⁄  
 
This clustered cardiometabolic risk score has been used successfully in recent investigations 
(Carson and Janssen, 2011, Ekelund et al., 2006, Franks et al., 2004) and in contrast to a binary 
definition for the metabolic syndrome (presence/absence), this approach provides a continuous 
risk score that increases statistical power. Although the continuous metabolic syndrome risk 
score is a valid alternative for epidemiological analyses (Wijndaele et al., 2006), the binary 
definition still remains the method of choice in clinical practice. 
 
Hypertriglyceridemic waist phenotype assessment 
 
The hypertriglyceridemic waist phenotype (Lemieux et al., 2000) was also used to identify 
individuals at increased cardiometabolic risk. For men, the hypertriglyceridemic waist phenotype 
is defined as a waist circumference of 90 cm or more and a triglyceride level of 2.0 mmol/L or 
more (Blackburn et al., 2009). For women, the hypertriglyceridemic waist phenotype is defined 
as a waist circumference of 85 cm or more and a triglyceride level of 1.5 mmol/L or more 




Numerous variables were measured via self-reported questionnaires at baseline and year 6. These 
included age, sex, smoking habits (smoker or nonsmoker), total annual family income (Canadian 
dollars per year), and coffee intake (number of cups per day). Additionally, daily energy 
intake (kcal/day) and alcohol consumption (g/day) were assessed with a 3-day food record 
(Tremblay et al., 1983). This method of dietary assessment has been shown to provide a 
relatively reliable measurement of food intake in this population (Tremblay et al., 1983). Finally, 
physical work capacity at a heart rate of 150 bpm (PWC150), determined by a progressive 
exercise test on a modified Monark cycle ergometer, was used as an indicator of 
cardiorespiratory fitness, as previously described (Bouchard et al., 1984). PWC150 is expressed in 
kiloponds/meter (kpm). We originally included moderate-to-vigorous physical activity (MVPA, 
self-reported from a 3-day physical activity diary) as a covariate in our analyses but decided to 
use cardiorespiratory fitness instead because (i) MVPA did not fit the definition of a confounding 
variable (i.e. variable correlated with both the exposure and outcome); (ii) self-reported variables 
are less accurate than objective measures; and (iii) we were limited by the number of covariates 
to enter in our models given the small sample size. These 8 covariates have been chosen because 
they all fit the definition of a confounding variable, i.e. an extraneous variable that correlates 
with both the independent variable (sleep) and the dependent variable (metabolic syndrome). 
Given that over-fitting can be a concern with our relatively small sample size, different analyses 
were conducted to assess model fit (including testing for multicollinearity) and it resulted that 




Since there was no statistically significant gender interaction between sleep duration and the 
outcome variables, data for both sexes were combined to improve clarity and maximize power. 
Baseline characteristics of participants by sleep duration group were compared by analysis of 
variance (continuous variables) or chi-squared test (categorical variables). A Tukey post-hoc 
test was used to contrast mean differences. Multivariate logistic regression analysis was used to 
evaluate the relative risk for the development of the metabolic syndrome or hypertriglyceridemic 
waist phenotype in short and long sleepers over the 6-year follow-up period. The 7–8 h sleep 
duration category was used as the reference group. The model was adjusted for age, sex, 
smoking habits, total annual family income, alcohol consumption, coffee intake, daily caloric 
intake, and cardiorespiratory fitness. Relative risks (RR) and 95% confidence intervals (CI) were 
reported. Because some individuals in this study came from the same nuclear family and are 
biologically related, we adjusted for clustering in the analyses using the generalized estimating 
equations statistical method to avoid underestimation of standard deviations. This procedure 
allowed us to model sleep duration and covariates as repeated measures as two time points 
(baseline and 6 years later), thus taking into account both measures over time. A 2-tailed P value 
of less than 0.05 was the threshold to indicate statistical significance. All statistical analyses were 




Baseline characteristics of participants within each sleep duration group are shown in Table 1. 
Among the 293 Caucasian participants of this study, 10 (3.4%) had diagnosed type 2 diabetes, 
and 27 (9.2%) had diagnosed hypertension. Over the 6-year follow-up period, 11 new cases of 
type 2 diabetes and 18 new cases of hypertension were observed. Short sleepers had a 
significantly higher body mass index, waist circumference, and fasting insulin concentrations 
compared to those sleeping 7 to 8 h per night. Short sleepers also reported drinking more coffee 
than long sleepers. 
 
Overall, 64 participants (21.8% of the sample) had the metabolic syndrome at baseline. There 
were 29 new cases of metabolic syndrome that developed over the 6-year follow-up period 
(incidence rate of 9.9%). Likewise, 53 participants (18.1% of the sample) had the 
hypertriglyceridemic waist phenotype at baseline and 22 new cases occurred over this period 
(incidence rate of 7.5%). As shown in Fig. 1, an inverse J-shaped relationship between sleep 
duration and the development of the metabolic syndrome or hypertriglyceridemic waist 
phenotype was observed (P < 0.05). 
 
The results of the multivariate logistic regression analysis assessing the relationship between 
sleep duration and the development of metabolic syndrome or hypertriglyceridemic waist 
phenotype are summarized in Table 2, Table 3. Short sleepers were significantly more at risk of 
developing the metabolic syndrome or the hypertriglyceridemic waist phenotype compared to 
those sleeping 7 to 8 h per night, after adjusting for covariates. However, long sleep duration was 
not associated with an increased risk of developing the metabolic syndrome or the 
hypertriglyceridemic waist phenotype (either unadjusted or adjusted models). Likewise, the 
continuous metabolic syndrome risk score increased significantly more in short sleepers (but not 
long sleepers) compared to adequate sleepers over the 6-year follow-up period after adjustment 
for covariates (data not shown). Of note, the use of another definition for the metabolic 
syndrome (e.g. International Diabetes Federation) did not change the associations. Among the 
individual components of the metabolic syndrome, abdominal adiposity (followed by HDL 
cholesterol) was the component that changed to the greatest extent in short-duration sleepers 
over the 6-year follow-up period (data not shown). 
 
Table 1. Baseline characteristics of participants according to sleep duration group.  
≤ 6 h per night 
(n = 38) 
7–8 h per night 
(n = 215) 
≥ 9 h per night 
(n = 40) 
P 
Age (years) 41.0 ± 13.6 39.2 ± 14.3 39.4 ± 14.8 0.78 
Sex 
    
Men (%) 55 46 35 
 
Women (%) 45 54 65 0.20 
Body mass index (kg/m2) 28.4 ± 5.1a 25.6 ± 5.7 26.8 ± 6.7 < 0.01 
Waist circumference (cm) 91.6 ± 14.4a 83.8 ± 15.6 84.9 ± 17.5 < 0.01 
Fasting glucose (mmol/L) 5.44 ± 1.15 5.21 ± 1.21 4.93 ± 0.49 0.18 
Fasting insulin (pmol/L) 86.7 ± 68.1a 60.8 ± 48.8 81.3 ± 68.9 0.01 
Systolic blood pressure (mm Hg) 115 ± 12 117 ± 15 121 ± 19 0.20 
Diastolic blood pressure (mm Hg) 74 ± 11 72 ± 10 74 ± 11 0.45 
Fasting triglycerides (mmol/L) 1.63 ± 1.18 1.58 ± 2.11 1.48 ± 0.76 0.85 
HDL cholesterol (mmol/L) 1.21 ± 0.35 1.25 ± 0.34 1.26 ± 0.36 0.72 
Smoking habits 
    
Nonsmoker (%) 74 86 83 
 
Smoker (%) 26 14 17 0.14 
Total annual family income ($C) 61,389 ± 29,510 58,578 ± 24,351 56,750 ± 26,446 0.72 
Alcohol consumption (g/day) 9.3 ± 15.7 6.8 ± 12.9 9.4 ± 19.7 0.53 
Coffee intake (cups/day) 3.03 ± 2.31b 2.61 ± 2.11 2.19 ± 1.81 < 0.05 
Energy intake (kcal/day) 2498 ± 682 2313 ± 760 2218 ± 587 0.22 
PWC150 (kpm) 753 ± 349 625 ± 268 588 ± 241 0.07 
Abbreviations: HDL, high-density lipoprotein; PWC150, physical work capacity at a heart rate of 150 bpm. Values 
are mean ± SD or n (%). Statistical significance was assessed by analysis of variance with continuous variables and 
by a chi-squared test with categorical variables. A Tukey post-hoc test was used to contrast mean differences. 
a Significantly different from the 7–8 h sleeping group. 
b Significantly different from the ≥ 9 h sleeping group. 
 
 
Fig. 1. Development of the metabolic syndrome (A) and the hypertriglyceridemic waist phenotype (B) between 
sleep duration groups over the 6-year follow-up period (until 2001) in adults from the greater Quebec City area 
(Canada). Data are presented as percentage. The metabolic syndrome was defined according to the American Heart 
Association/National Heart, Lung, and Blood Institute's criteria. Statistical significance was assessed by a chi-
squared test (P < 0.05 for both analyses). Short sleepers (≤ 6 h of sleep per night; n = 38), adequate sleepers (7–8 h 
of sleep per night; n = 215), and long sleepers (≥ 9 h of sleep per night; n = 40). 
 
Table 2. Relative risk for the incidence of metabolic syndrome by sleep duration group over the 
6-year follow-up period (until 2001) in adults from the greater Quebec City area (Canada).  
Sleep duration group 
≤ 6 h per night (n = 38) 7–8 h per night (n = 215) ≥ 9 h per night (n = 40) 
RR 95% CI Reference RR 95% CI 
Model 1 2.01 1.30–3.05 1.00 1.31 0.80–2.12 
Model 2 1.74 1.05–2.72 1.00 1.10 0.51–1.98 
The metabolic syndrome was defined according to the American Heart Association/National Heart, Lung, and Blood 
Institute's criteria. 
Model 1: adjusted for age and sex. 
Model 2: adjusted for age, sex, smoking habits, total annual family income, alcohol consumption, coffee intake, 
daily caloric intake, and cardiorespiratory fitness. 
Abbreviations: RR, relative risk; CI, confidence interval. 
 
Table 3. Relative risk for the incidence of the hypertriglyceridemic waist phenotype by sleep 
duration group over the 6-year follow-up period (until 2001) in adults from the greater Quebec 
City area (Canada).  
Sleep duration group 
≤ 6 h per night (n = 38) 7–8 h per night (n = 215) ≥ 9 h per night (n = 40) 
RR 95% CI Reference RR 95% CI 
Model 1 2.32 1.41–3.51 1.00 1.52 0.97–2.38 
Model 2 1.82 1.16–2.79 1.00 1.13 0.58–1.98 
The hypertriglyceridemic waist phenotype was defined as having both a high waist circumference (≥ 90 cm in men 
and ≥ 85 cm in women) and increased fasting triglyceride levels (≥ 2.0 mmol/L in men and ≥ 1.5 mmol/L in 
women). 
Model 1: adjusted for age and sex. 
Model 2: adjusted for age, sex, smoking habits, total annual family income, alcohol consumption, coffee intake, 
daily caloric intake, and cardiorespiratory fitness. 




Overall, we observed that sleeping less than 6 h per night was associated with an increased risk 
of developing features of the metabolic syndrome in this sample of adults from the Quebec 
Family Study. In contrast, long sleep duration was not associated with a higher incidence of 
metabolic syndrome or hypertriglyceridemic waist phenotype compared to sleeping between 7 
and 8 h a day. Our results strongly suggest that short sleeping habits should be further 
investigated as a lifestyle factor that may predispose individuals to cardiometabolic disease risk. 
 
The results of the present study agree with those recently published by Choi et al. 
(2011) showing that only short sleep duration (less than 6 h per day) was a significant risk factor 
for the development of the metabolic syndrome in midlife women. However, the present study 
had a longer follow-up period (6 years vs. 2–4 years), included important covariates that were 
not assessed in the Choi et al. study (e.g. daily caloric intake, cardiorespiratory fitness, 
socioeconomic status), and we added the concept of hypertriglyceridemic waist phenotype. 
Furthermore, Choi et al. (2011) relied on a different ethnic group (Korean cohort) in which 
different waist circumference cut-offs are recommended. 
 
Our findings are also consistent with the few cross-sectional studies published on the association 
between sleep duration and the metabolic syndrome. While short sleep duration has been shown 
to be associated with the presence of metabolic syndrome in some studies (Kobayashi et al., 
2011, Wu et al., 2012), both short and long sleep durations were related to an increased risk of 
the metabolic syndrome and its components in other studies (Choi et al., 2008, Hall et al., 2008). 
Conversely, Arora et al. (2011) observed that long sleep duration was associated with a greater 
risk of metabolic syndrome in older Chinese. Although the latter study is not in line with the 
evidence published to date on this topic, the authors of the study speculated that the difference 
could perhaps be explained by an attenuation of the sleep–metabolic syndrome relationship with 
age or possibly the fact that long sleep may be a consequence of ill health. 
 
There are a number of biological mechanisms through which reduced sleep durations may lead to 
the metabolic syndrome. Experimental sleep restriction has been shown to decrease glucose 
tolerance and increase insulin resistance, sympathetic nervous system activity, blood pressure 
and blood cortisol concentrations (Cappuccio et al., 2011, Knutson, 2010, Leproult and Van 
Cauter, 2010, Spiegel et al., 2009). Low-grade inflammation has also been shown to increase 
with short sleep and could possibly impact cardiometabolic risk (Miller and Cappuccio, 2007). 
Moreover, lack of sleep is generally associated with an increase in food intake and can contribute 
to weight gain and obesity (Chaput and Tremblay, 2012). However, future studies will be needed 
to elucidate the pathways between insufficient sleep and cardiometabolic risk, and to rule out 
reverse causation. 
 
Accumulating evidence suggests that a sleep duration of 7–8 h per night in adults is associated 
with the maintenance of good health (National Sleep Foundation, 2002). Both short sleep 
duration and poor sleep quality are pervasive in modern societies and many individuals still 
believe that sleep is a waste of time (Matricciani et al., 2012, National Sleep Foundation, 2002). 
Insufficient sleep adversely affects physiological and psychological health and impacts certain 
behaviors of individuals (e.g. eating habits, physical activity participation, alcohol consumption) 
so that the maintenance of overall health is potentially compromised by insufficient sleep 
(Chaput and Tremblay, 2012, McNeil et al., 2013). The fact that short sleep duration was still 
associated with the development of the metabolic syndrome or the hypertriglyceridemic waist 
after adjusting for many possible confounding factors suggests that the relationship was 
independent of these covariates. 
 
Strengths and limitations of the study 
 
Strengths of this study include its longitudinal design and the adjustment for many important 
variables that could confound the relationship between short sleep duration and the incidence of 
metabolic syndrome (e.g. caloric intake, cardiorespiratory fitness and socioeconomic status). 
Furthermore, data were obtained from both men and women and we used an approach that 
should minimize confounding with repeated measures of sleep duration and covariates. We also 
added the hypertriglyceridemic waist phenotype to provide another simple screening tool of 
clustering metabolic abnormalities. However, our results need to be interpreted in light of the 
following limitations. First, the relatively small sample size limits statistical power and more 
high quality and well powered studies are needed to better appreciate the influence of sleeping 
habits on features of the metabolic syndrome. Second, although good agreement has been found 
in previous studies between self-reported sleep durations and those obtained through actigraphic 
monitoring (Hauri and Wisbey, 1992, Lockley et al., 1999), the single question approach does 
not provide information on sleep quality. Third, the incidence rate of metabolic syndrome or 
hypertriglyceridemic waist phenotype was low over the 6-year follow-up period and could 
impact the results reported in the present study. Fourth, the external generalizability of our 
findings may be restricted to adults of Western European descent. Finally, the possibility of 
residual confounding by unmeasured variables is always a possibility in observational 




In summary, the present study provides evidence that short sleep duration is associated with an 
increased risk of developing features of the metabolic syndrome in adults. Replication studies are 
warranted and future studies should examine pathways by which reduced sleep duration affects 
the development of metabolic syndrome. 
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